Authors:
ALLEN DG
BAAK J
BELPOMME D
BEREK JS
BERTELSEN K
HUININK WWT
VANDERBURG MEL
CALVERT AH
CONTE PE
DAUPLAT J
EISENHAUER EA
FAVALLI G
HACKER NF
HAMILTON TC
HANSEN HH
HANSEN M
VANHOUWELINGEN HC
KAYE SB
LEVIN L
LUND B
NEIJT JP
OZOLS RF
PICCART MJ
RUSTIN GJS
SESSA C
SOUTTER WP
THIGPEN JT
TROPE C
VERMORKEN JB
DEVRIES EGE
Citation: Dg. Allen et al., ADVANCED EPITHELIAL OVARIAN-CANCER - 1993 CONSENSUS STATEMENTS, Annals of oncology, 4, 1993, pp. 83-88
Authors:
VANDENBERG TA
PRITCHARD KI
EISENHAUER EA
TRUDEAU ME
NORRIS BD
LOPEZ P
VERMA SS
BUCKMAN RA
MULDAL A
Citation: Ta. Vandenberg et al., PHASE-II STUDY OF WEEKLY EDATREXATE AS 1ST-LINE CHEMOTHERAPY FOR METASTATIC BREAST-CANCER - A NATIONAL-CANCER-INSTITUTE OF CANADA CLINICAL-TRIALS GROUP-STUDY, Journal of clinical oncology, 11(7), 1993, pp. 1241-1244
Authors:
PEEREBOOM DM
DONEHOWER RC
EISENHAUER EA
MCGUIRE WP
ONETTO N
HUBBARD JL
PICCART M
GIANNI L
ROWINSKY EK
Citation: Dm. Peereboom et al., SUCCESSFUL RETREATMENT WITH TAXOL AFTER MAJOR HYPERSENSITIVITY REACTIONS, Journal of clinical oncology, 11(5), 1993, pp. 885-890
Authors:
STEWART DJ
EISENHAUER EA
SKILLINGS J
PRITCHARD KI
BUCKMAN R
VANDENBERG T
VERMA S
AITKEN S
NORRIS B
Citation: Dj. Stewart et al., PHASE-II STUDY OF ORAL MENOGARIL AS 1ST LINE CHEMOTHERAPY FOR ADVANCED BREAST-CANCER - A NATIONAL-CANCER-INSTITUTE-OF-CANADA CLINICAL-TRIALS GROUP-STUDY, Annals of oncology, 3(3), 1992, pp. 201-204